ArticleBriefings in bioinformatics2025
scRDAN: a robust domain adaptation network for cell type annotation across single-cell RNA sequencing data.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Single-cell RNA sequencing technology facilitates the recognition of diverse cell types and subgroups, playing a crucial role in investigating cellular heterogeneity. Cell type annotation, a crucial process in single-cell RNA sequencing analysis, is often influenced by noise and batch effects. To address these challenges, we propose scRDAN, which is a robust domain adaptation network comprising three modules: the denoising domain adaptation module, the fine-grained discrimination module, and the robustness enhancement module. The denoising domain adaptation module mitigates noise interference through feature reconstruction in domains, while leveraging adversarial learning to align data distributions, improving annotation accuracy and robustness against batch effects. The fine-grained discrimination module maintains intra-class compactness and enhances inter-class separability, reducing feature overlap and improving cell type distinction. Finally, the robustness enhancement module introduces noise from various perspectives in both domains, enhancing robustness and generalization. We evaluate scRDAN on simulated, cross-platforms, and cross-species datasets, comparing it with advanced methods. Results demonstrate that scRDAN outperforms existing methods in handling batch effects and cell type annotation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.